Clinical Trial Update: Venetoclax Combined With Azacitidine for Consolidation Therapy in AML [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of Venetoclax and Azacitidine as consolidation therapy for Acute Myeloid Leukemia; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Consolidation Therapy | Phase 2 | Status: NOT_YET_RECRUITING